Discovery of serum metabolites for diagnosis of progression of mild cognitive impairment to Alzheimer's disease using an optimized metabolomics method

• DOI: 10.1039/c5ra19349d
• Publication Date: 2016-01-05T09:30:21Z
• Authors: Qun Liang; Han Liu; Tianyu Zhang; Yan Jiang; Haitao Xing; Ai-hua Zhang
• Keywords: 0303 health sciences; 03 medical and health sciences; 3. Good health

A nontargeted metabolomics approach was developed to examine metabolic differences in serum samples from the mild cognitive impairment and Alzheimer's disease subjects.